article thumbnail

Outsourcing In Drug Development: A Key Strategy for Sustainable Growth

Electronic Health Reporter

The pharmaceutical industry is constantly evolving, driven by advances in science, technology, and patient needs. One of the most prominent trends shaping this industry is the outsourcing of various stages of drug development. Illegal copying is prohibited.

article thumbnail

Bipartisan House Task Force releases report on AI innovation

Mobi Health News

The task force gathered information on AI issues from industry, government, civil society and academia and offered guiding principles, 66 key findings and 89 recommendations. Among the key findings: AI's use in healthcare may reduce administrative burdens and hasten drug development and clinical diagnosis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.

article thumbnail

Pharma – 2025 Health IT Predictions

Healthcare IT Today

Check out our community’s Pharma predictions: Dave Latshaw, CEO at BioPhy The competitive dynamics of the pharmaceutical industry will undergo substantial reorganization in 2025. The pharmaceutical industry is poised for a transformative shift in 2025, with artificial intelligence becoming deeply embedded in core operations.

article thumbnail

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D., Petra Jantzer, Ph.D.,

article thumbnail

Demystifying AI: A Review of the Fundamentals and Applications in Drug Development

ActiGraph

Companies across many industries are exploring the use cases and potential benefits that AI-based tools can bring to their operations, prompting regulatory bodies to assess the implications. The field of drug development is no exception.